ArticleJAMA network open2023

Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer.

Hayato Kawachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.